NCT03410654View on ClinicalTrials.gov

Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 24, 2018

Primary Completion Date

January 1, 2024

Study Completion Date

July 1, 2024

Conditions
Kidney Transplant; Complications
Interventions
DRUG

Tacrolimus, Extended Release, (Envarsus Xr)

After conversion of tacrolimus immediate release to tacrolimus extended release.

Trial Locations (1)

06520

Yale New Haven Transplantation Center, New Haven

Sponsors

Collaborators (1)

Veloxis Pharmaceuticals
All Listed Sponsors
collaborator

Veloxis Pharmaceuticals

INDUSTRY

lead

Yale University

OTHER